BioSpace News Archive

Biotech Beach

Getting to the Root of the Disease: Developing Drugs Against the Hard-to-Target Wnt Pathway

The Wnt pathway is a mastermind signaling pathway in your cells, creating a complex dance of proteins that must be choreographed and executed correctly for proper cell functioning.

January 21, 2020
·
4 min read
·
Chelsea Weidman Burke
Takeda Eyes 12 New Drug Approvals by 2024, Hemophilia Gene Therapy May Not be a Competitor

Over the past year, the company strived to transform itself into becoming a frontrunner in multiple areas, including cell and gene therapies.

January 21, 2020
·
3 min read
·
Alex Keown
How to Be a Successful Woman Leader in a Male-Driven Industry

If you want to be a successful woman in the biotech field, here are a few tried and true tips. These can for sure help you in your professional career.

January 21, 2020
·
3 min read
·
Kymberlie Krieger
Biotech Bay

Landmark Nature Publication Demonstrates the Power of the Fluidigm Hyperion Imaging System to Identify Novel Cellular Signatures That Correlate with Distinct Clinical Outcomes

Retrospective Clinical Study Uses Highly Multiplexed Imaging Mass Cytometry to Reveal Previously Unknown Features of the Tumor Microenvironment and Novel Breast Cancer Subgroups

January 21, 2020
·
6 min read
Policy

Pharming receives EMA approval of new facility for expansion of RUCONEST® production

Pharming Group N.V. announced it has received European Medicines Agency approval of a Type II Variation for a new production facility for the Company’s lead product, RUCONEST®.

January 21, 2020
·
4 min read
Exosomics implements NanoFCM’s NanoAnalyzer at its Siena facility to provide advanced extracellular vesicles-focused analytical services

Exosomics SpA, the leading extracellular vesicles biotech company, announced that it has implemented NanoFCM Co., Ltd’s NanoAnalyzer instrument to offer sophisticated contract research and measurement services worldwide.

January 21, 2020
·
3 min read
Business

Sensyne Health Interim Results

Sensyne Health plc, the British Clinical AI technology company, announces its Interim Results for the 6 months ended 31 October 2019.

January 21, 2020
·
3 min read
Pharm Country

Hoth Completes Animal Safety Study of Proprietary BioLexa Platform for the Treatment of Atopic Dermatitis

Hoth Therapeutics, Inc. (NASDAQ: HOTH), a biopharmaceutical company focused on developing new generation therapies for dermatological and immunological disorders such as atopic dermatitis, psoriasis, asthma and acne, announced today that the Company has concluded its “In-life 28-day animal study” for their BioLexa Platform

January 21, 2020
·
4 min read
Tauriga Sciences, Inc. Participating this Week as Main Floor Corporate Exhibitor at PGA Merchandise Show 2020 in Orlando, Florida

Tauriga Sciences, Inc. announced that it is participating, this week, as a main floor Exhibitor at the prestigious Tradeshow – PGA Merchandise Show 2020.

January 21, 2020
·
5 min read
Bio NC

RedHill Biopharma to Focus Commercial Efforts on Talicia® and Aemcolo®; Discontinuing Promotion of Legacy Products

RedHill Biopharma Ltd. (Nasdaq: RDHL) (Tel-Aviv Stock Exchange: RDHL) (“RedHill” or the “Company”), a specialty biopharmaceutical company primarily focused on commercialization and development of proprietary drugs for the treatment of gastrointestinal diseases, today announced its decision to discontinue its co-promotion and commercialization agreements for Donnatal® and EnteraGam®

January 21, 2020
·
10 min read